CEO: Jack Yongfeng Zhang

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable & inhalation products. Its products are used in hospitals or urgent care clinical settings.


Key numbers

Market Capitalization:808272360
Shares Outstanding: 46938000
Float: 35593742.532
Next Earning Date:2020-03-18
TTm EPS: 1.1011
TTm Dividend Rate:
200 days moving average:20.99
50 days moving average: 19.88
One day percent Change: -11.78



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,